Maze Therapeutics MAZE
NASDAQ MAZE
$31.95 -0.63 (-1.93%)
At close: Oct 22, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Short-term Investments (2025 - 2026)

Updated

Maze Therapeutics' Short-term Investments was $208.44 million in Q2 2026, up 35.7% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Short-term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, Short-term Investments at Maze Therapeutics came in at $152.67 million.

  • Per Business Quant data, MAZE's Short-term Investments in the three quarters before Q2 2026 was $153.62 million (Q1 2026), $152.67 million (Q4 2025) and $67.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Maze Therapeutics 1.77 Bn 284.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 208.44 Mn
Mar 31, 2026 153.62 Mn
Dec 31, 2025 152.67 Mn
Sep 30, 2025 67.16 Mn
API Access

Maze Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=MAZE&period=max&api_key=YOUR_API_KEY